Search all medical codes

Tetanus toxoid adsorbed, for intramuscular use

CPT4 code

Name of the Procedure:

Tetanus Toxoid Adsorbed for Intramuscular Use
Common Names: Tetanus shot, Tetanus vaccination, Tetanus toxoid vaccine.

Summary

The tetanus toxoid adsorbed vaccine is an immunization given via an intramuscular injection. It helps to protect against tetanus, a serious bacterial infection that affects the nervous system and muscles.

Purpose

This vaccine addresses the prevention of tetanus, which is caused by Clostridium tetani bacteria found in soil, dust, and manure. The goal is to prevent infection that can result in severe muscle spasms, difficulty breathing, and potentially death.

Indications

  • Individuals who have not completed their tetanus vaccination series.
  • Adults and children requiring booster shots every 10 years.
  • Patients with wounds that have a high risk of contamination and tetanus infection.

Preparation

  • No specific fasting or dietary restrictions are required.
  • Inform the healthcare provider of any allergies, current medications, and medical history.
  • It is helpful to review immunization records beforehand.

Procedure Description

  1. The patient will be seated comfortably.
  2. The injection site (typically the upper arm) will be cleaned with an antiseptic wipe.
  3. Using a sterile needle, the healthcare provider will inject the vaccine into the muscle.
  4. The site may be covered with a small bandage.

Duration

The injection procedure typically takes only a few minutes.

Setting

The vaccine is usually administered in outpatient clinics, doctor's offices, or pharmacies.

Personnel

A trained healthcare professional such as a nurse or doctor will administer the injection.

Risks and Complications

  • Common: Soreness, redness, or swelling at the injection site, mild fever, or fatigue.
  • Rare: Severe allergic reactions, Guillain-Barré syndrome, or anaphylaxis.

Benefits

The primary benefit is immunity against tetanus, significantly reducing the risk of infection. Immunity usually develops within a few weeks and lasts for about ten years.

Recovery

  • Patients can resume normal activities immediately.
  • It's recommended to stay in the clinic for 15-30 minutes post-injection to monitor for any adverse reactions.
  • Apply a cold pack to reduce discomfort at the injection site if needed.

Alternatives

  • There are combination vaccines (e.g., Tdap) that protect against tetanus, diphtheria, and pertussis.
  • The benefits of combined vaccines include broader protection with fewer injections.
  • No vaccination is an alternative, but this leaves a person susceptible to contracting tetanus.

Patient Experience

  • The injection may cause a brief, sharp pain.
  • Minor swelling and tenderness can occur at the injection site.
  • Over-the-counter pain relievers can be used to manage any mild discomfort post-injection.

Similar Codes